Can metabolic syndrome substantially increase Parkinson’s risk?

Translate to Spanish or other 102 languages!

Past research shows that metabolic syndrome can lead to diseases like type 2 diabetes, stroke, atherosclerosisTrusted Source, atrial fibrillation, organ damageTrusted Source, pregnancy complicationsTrusted Source, and certain cancers. Image forillustration purposes.
Past research shows that metabolic syndrome can lead to diseases like type 2 diabetes, stroke, atherosclerosisTrusted Source, atrial fibrillation, organ damageTrusted Source, pregnancy complicationsTrusted Source, and certain cancers. Image forillustration purposes.
- Advertisement -

Medical News Today

As much as 31% of the world’s population has metabolic syndrome — a combination of several health issues, such as high blood pressure and abdominal obesity, that when blended can raise a person’s risk for several health conditions. 

Metabolic syndrome has also been linked to an increased risk for certain neurological conditions like cognitive declineAlzheimer’s disease, and Parkinson’s disease.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/can-metabolic-syndrome-substantially-increase-parkinsons-risk?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-08-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STC Student Emerges as a Model for Future Leaders in Occupational Therapy

Mega Doctor News By Selene Rodriguez Driven by a determination to help children...

STHS to Host Webinar on Health Impact of Alcohol Use, April 21st

Throughout the world, alcohol consumption is widespread and deeply normalized, often occurring during social gatherings, celebrations and as a way to relax. 

Physician Burnout Eases Overall, but Specialty Disparities Persist

Mega Doctor News American Medical Association CHICAGO — New data from the American Medical Association...

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -